Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Vitreoretinal surgery · Texas | Vitreoretinal surgery · Florida | |
|---|---|---|
| Surgeons, 2024 | 83 | 76 |
| Medicare fee-for-service cases | 6,824 | 6,413 |
| Growth since 2019 (Medicare FFS) | −3.6%/yr | −2.9%/yr |
| Forecast cases (Medicare FFS) | 7,210 in 2030 | 6,520 in 2030 |
| Forecast growth | +0.9%/yr to 2030 | +0.3%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.2 | 2.9 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 80% (+24 pts since 2019) | 87% (+11 pts since 2019) |
| Cases per surgeon | 82 | 84 |
| Top 10 surgeons' share | 34% | 45% |
| Surgeons growing | 11 | 19 |
| New since the base year | 12 | 7 |
| Likely to stop billing it | 11 by 2026 | 13 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $12K | $14K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.